R&D | January 06, 2026
Insilico Medicine teams up with Servier to fast-track AI-driven cancer drugs
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
His professional background also includes key experience at Matrix Labs and Sun Pharma
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
The plant is expected to enhance regional supply capabilities
CX-5461 is “the world's first and most advanced G-quadruplex (G4) stabilizer in development
The primary goal of the collaboration is joint research into trending and next-generation molecules
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
The collaboration aims to combine synthetic biology with cutting-edge detection technology to create a first-of-its-kind oral pill embedded with tumor-targeting sensors
The move strengthens Sanofi’s presence in adult immunization by combining Dynavax’s innovative vaccines with Sanofi’s global scale and development capabilities
The company along with its subsidiaries has overall bed capacity of 8800+ beds as on 30th September, 2025
Subscribe To Our Newsletter & Stay Updated
